Dahan Michel
Insider CIK 1669737 · AKBA SVP, Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | S Sale | 2024-05-13 | 2024-05-14 | 34,840 | $1.26 | $43.9K | 672,092 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2024-02-29 | 2024-03-01 | 8,661 | $1.58 | $13.7K | 706,932 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-29 | 10,744 | $1.52 | $16.3K | 715,593 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 224,000 | — | $0 | 224,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 149,300 | — | $0 | 726,337 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-05-25 | 2023-05-25 | 95,478 | $1.22 | $116.5K | 574,037 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2023-05-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-05-24 | 2023-05-25 | 200,000 | — | $0 | 669,515 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-05-12 | 2023-05-16 | 200,000 | — | $0 | 469,515 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 1,878 | $0.88 | $1.7K | 269,515 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 8,058 | $0.88 | $7.1K | 281,869 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 10,476 | $0.88 | $9.2K | 271,393 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-02-27 | 2023-03-01 | 10,090 | $0.81 | $8.2K | 289,927 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 6,873 | $2.17 | $14.9K | 302,122 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 1,232 | $2.17 | $2.7K | 297,017 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 6,873 | $2.17 | $14.9K | 295,249 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-02-28 | 2022-03-02 | 50,000 | — | $0 | 308,995 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-02-28 | 2022-03-02 | 6,555 | $2.15 | $14.1K | 258,995 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-01 | 1,211 | $3.40 | $4.1K | 265,550 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-03-16 | 2021-03-18 | 11,648 | — | $0 | 266,761 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-02 | 6,602 | $3.40 | $22.4K | 263,058 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-02 | 7,945 | $3.40 | $27.0K | 255,113 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-02-26 | 2021-03-02 | 110,000 | — | $0 | 110,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-02-26 | 2021-03-02 | 62,000 | — | $0 | 269,660 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-02-28 | 2020-03-02 | 65,000 | — | $0 | 211,932 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2020-02-28 | 2020-03-02 | 6,972 | $8.70 | $60.7K | 204,960 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | D To issuer | 2019-04-11 | 2019-04-12 | 11,909 | $7.70 | $91.7K | 146,932 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-02-28 | 2019-03-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-02-28 | 2019-03-05 | 65,000 | — | $0 | 158,841 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | F Tax w/h | 2018-12-12 | 2018-12-13 | 23,385 | $8.94 | $209.1K | 93,841 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-02-28 | 2018-03-02 | 27,500 | — | $0 | 27,500 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2018-02-28 | 2018-03-02 | 19,400 | — | $0 | 115,226 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-10-02 | 2017-10-04 | 1,398 | $19.64 | $27.5K | 95,826 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-09-28 | 2017-10-02 | 5,000 | $19.30 | $96.5K | 97,224 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-08-15 | 2017-08-17 | 5,000 | $15.00 | $75.0K | 102,224 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-07-03 | 2017-07-06 | 1,399 | $14.26 | $19.9K | 107,224 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-04-03 | 2017-04-04 | 1,401 | $9.18 | $12.9K | 108,623 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-02-21 | 2017-02-23 | 62,500 | $10.14 | $633.8K | 62,500 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2017-02-21 | 2017-02-23 | 39,500 | — | $0 | 110,024 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-01-01 | 2017-01-03 | 1,629 | $10.49 | $17.1K | 70,524 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2016-10-01 | 2016-10-04 | 1,401 | $8.95 | $12.5K | 72,153 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2016-07-05 | 2016-07-06 | 1,402 | $7.47 | $10.5K | 73,554 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2016-04-04 | 2016-04-05 | 1,401 | $9.41 | $13.2K | 74,956 | SEC↗ |